The University of Chicago Header Logo

Connection

James Vardiman to Rituximab

Back to Details
This is a "connection" page, showing publications James Vardiman has written about Rituximab.
James Vardiman
Connection Strength
0.012
Rituximab
  1. Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). Blood. 2003 Jan 01; 101(1):6-14.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.